Zura Bio Ltd ZURA
- tibulizumab — Hidradenitis Suppurativa Phase 2
- tibulizumab — Diffuse Cutaneous Systemic Sclerosis Phase 2
- tibulizumab — Polymyalgia Rheumatica
IL-17 (1 companies · 3 programs)
Companies with an active program directed at IL-17.
Companies with an active program directed at IL-17.